Literature DB >> 6741224

Determination of parasite-specific immunoglobulins using the ELISA in patients with echinococcosis treated with mebendazole.

B Gottstein, J Eckert, W Woodtli.   

Abstract

Parasite-specific immunoglobulin classes were determined by the ELISA in sera of 19 patients with cystic or alveolar echinococcosis before and after 2 years (+/- 4 months) of continuous treatment with mebendazole at daily doses of 35-50 mg/kg body weight. In the majority of cases IgG decreased and IgA and IgE decreased or disappeared. In contrast, four patients with progressive disease showed reverse tendencies with increasing IgG, IgA and IgE concentrations during the same period.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6741224     DOI: 10.1007/BF00927825

Source DB:  PubMed          Journal:  Z Parasitenkd        ISSN: 0044-3255


  7 in total

1.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

2.  [Chemotherapy of echinococcosis in laboratory animals].

Authors:  J Eckert; G Barandun; J Pohlenz
Journal:  Schweiz Med Wochenschr       Date:  1978-07-22

3.  [Echinococcosis therapy].

Authors: 
Journal:  Dtsch Med Wochenschr       Date:  1979-10-12       Impact factor: 0.628

Review 4.  Chemotherapy for larval echinococcosis in animals and humans: report of a workshop.

Authors:  P M Schantz; H Van den Bossche; J Eckert
Journal:  Z Parasitenkd       Date:  1982

5.  Human echinococcosis: follow-up of 23 patients treated with mebendazole.

Authors:  P Kern
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

6.  Serological differentiation between Echinococcus granulosus and E. multilocularis infections in man.

Authors:  B Gottstein; J Eckert; H Fey
Journal:  Z Parasitenkd       Date:  1983

7.  Treatment of human echinococcosis with mebendazole. Preliminary observations in 28 patients.

Authors:  E Müller; A Akovbiantz; R W Ammann; J Bircher; J Eckert; K Wissler; F Witassek; B Wüthrich
Journal:  Hepatogastroenterology       Date:  1982-12
  7 in total
  14 in total

1.  Assessment of Echinococcus granulosus somatic protoscolex antigens for serological follow-up of young patients surgically treated for cystic echinococcosis.

Authors:  Nadia Ben Nouir; Sandra Nuñez; Christian Gianinazzi; Mohamed Gorcii; Norbert Müller; Abdellatif Nouri; Hamouda Babba; Bruno Gottstein
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

2.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

3.  Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions.

Authors:  V Godot; S Harraga; I Beurton; M Deschaseaux; E Sarciron; B Gottstein; D A Vuitton
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

4.  In vitro synthesized immunoglobulin A from nu/+ and reconstituted nu/nu mice against a dominant surface antigen of Giardia lamblia.

Authors:  B Gottstein; P Deplazes; I Tanner
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

5.  The damages of high intensity focused ultrasound to transplanted hydatid cysts in abdominal cavities of rabbits with aids of ultrasound contrast agent and superabsorbent polymer.

Authors:  Ai-Bo Liu; Hui Cai; Bin Ye; Lu-Lu Chen; Meng-Ying Wang; Jing Zhang; Yi-Feng Zhao
Journal:  Parasitol Res       Date:  2013-03-03       Impact factor: 2.289

6.  Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.

Authors:  D Sturm; J Menzel; B Gottstein; P Kern
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

7.  [The long-term course of 60 patients with alveolar echinococcosis in continuous therapy with mebendazole (1976-85)].

Authors:  R Ammann; K Tschudi; M von Ziegler; F Meister; J Cotting; J Eckert; F Witassek; A Freiburghaus
Journal:  Klin Wochenschr       Date:  1988-11-01

8.  Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57B1/6J) or 'resistant' (C57B1/10) to secondary alveolar echinococcosis.

Authors:  B Gottstein; E Wunderlin; I Tanner
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  IgE-dependent humoral immune response in Echinococcus multilocularis infection: circulating and basophil-bound specific IgE against Echinococcus antigens in patients with alveolar echinococcosis.

Authors:  D A Vuitton; S Bresson-Hadni; D Lenys; F Flausse; M Liance; P Wattre; J P Miguet; A Capron
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

Review 10.  Molecular and immunological diagnosis of echinococcosis.

Authors:  B Gottstein
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.